Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Douglas Carr Insider Profile
4 Followers
Douglas Carr, SVP Finance & Operations at Century Therapeutics, holds 317.15K shares in Century Therapeutics (Ticker: IPSC). Most recently, Douglas Carr Sold $16,894 shares of Century Therapeutics on Nov 05, 2024 for an estimated value of 21.28K.
Douglas Carr Century Therapeutics (IPSC)SVP Finance & Operations
Century Therapeutics (IPSC)
SVP Finance & Operations
Ranked #10,201 out of 100,202 Corporate Insiders
Profitable Transactions
4 out of 4 Profitable Transactions
Average Return
+49.10%
Average return per transaction
Time Frame
Compare to
Insider Roles
SVP Finance & Operations
Roles that Douglas Carr holds in companies
Most Profitable Insider Trade
The most profitable trade made by Douglas Carr
Douglas Carr's Trading History
List of latest transactions for each holding click on a transaction to see Douglas Carr's performance on stock
You May Also Like
Douglas Carr insider profile FAQ
What is the percentage of profitable transactions made by Douglas Carr?
The percentage of profitable transactions made by Douglas Carr is 100%.
What is the average return per transaction made by Douglas Carr?
The average return per transaction made by Douglas Carr is 49.10%.
What stocks does Douglas Carr hold?
Douglas Carr holds: IPSC stocks.
What was Douglas Carr’s latest transaction?
Douglas Carr latest transaction was an Informative Sell of $21.28K.
What was Douglas Carr's most profitable transaction?
Douglas Carr’s most profitable transaction was an Informative Sell of IPSC stock on February 7, 2024. The return on the trade was 75.80%.
What is Douglas Carr's role in Century Therapeutics?
Douglas Carr's role in Century Therapeutics is SVP Finance & Operations.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.